These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20153836)

  • 1. Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation.
    Glezerman IG; Jhaveri KD; Watson TH; Edwards AM; Papadopoulos EB; Young JW; Flombaum CD; Jakubowski AA
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):976-84. PubMed ID: 20153836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologic Complications of the Central Nervous System after Allogeneic Stem Cell Transplantation: The Role of Transplantation-Associated Thrombotic Microangiopathy as a Potential Underreported Cause.
    Sala E; Neagoie AM; Lewerenz J; Saadati M; Benner A; Gantner A; Wais V; Döhner H; Bunjes D
    Transplant Cell Ther; 2024 Jun; 30(6):586.e1-586.e11. PubMed ID: 38508452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
    Schoettler M; Lehmann L; Li A; Ma C; Duncan C
    Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic Microangiopathy Increases the Risk of Chronic Kidney Disease but Not Overall Mortality in Long-term Transplant Survivors.
    Li A; Gupta R; Amos CI; Davis C; Pao E; Lee SJ; Hingorani SR
    Transplant Cell Ther; 2021 Oct; 27(10):864.e1-864.e5. PubMed ID: 34217847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
    Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
    Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal Complications after Hematopoietic Stem Cell Transplantation: Role of Graft-Versus-Host Disease in Renal Thrombotic Microangiopathy.
    Mii A; Shimizu A; Yamaguchi H; Tsuruoka S
    J Nippon Med Sch; 2020 Mar; 87(1):7-12. PubMed ID: 31776318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
    Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
    Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Plasma Exchange does not Improve Renal Function in Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: An Institutional Experience.
    Sartain S; Shubert S; Wu MF; Srivaths P; Teruya J; Krance R; Martinez C
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):157-162. PubMed ID: 30144562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplants.
    Glezerman IG; Devlin S; Maloy M; Bui M; Jaimes EA; Giralt SA; Jakubowski AA
    Bone Marrow Transplant; 2017 May; 52(5):733-738. PubMed ID: 28092350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation.
    Postalcioglu M; Kim HT; Obut F; Yilmam OA; Yang J; Byun BC; Kupiec-Weglinski S; Soiffer R; Ritz J; Antin JH; Alyea E; Koreth J; Cutler C; Armand P; Paik JM; Leaf DE; Ho VT; Abdi R
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2344-2353. PubMed ID: 29758394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease.
    García-Martín P; Alarcón-Payer C; López-Fernández E; Moratalla L; Romero A; Sainz J; Ríos R; Jurado M
    Ann Pharmacother; 2015 Sep; 49(9):986-94. PubMed ID: 26160968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.
    Zhang XH; Liu X; Wang QM; He Y; Zhu XL; Zhang JM; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Fu HX; Chang YJ; Xu LP; Liu KY; Huang XJ
    Eur J Haematol; 2018 Feb; 100(2):171-181. PubMed ID: 29114931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.
    Ye Y; Zheng W; Wang J; Hu Y; Luo Y; Tan Y; Shi J; Zhang M; Huang H
    Hematol Oncol; 2017 Dec; 35(4):821-827. PubMed ID: 27245857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
    Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
    Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal thrombotic microangiopathy: a distinct entity in the spectrum of graft-versus-host disease.
    Gavriilaki E; Sakellari I; Karafoulidou I; Pasteli N; Batsis I; Mallouri D; Lazaridou A; Iskas M; Vardi A; Papalexandri A; Tsompanakou A; Papaemmanouil S; Ilias A; Anagnostopoulos A
    Int J Hematol; 2019 Nov; 110(5):529-532. PubMed ID: 31586304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review].
    Han W; Han Y; Chen J; Ma X; Chen F; Wu XJ; Qi JQ; Qiu HY; Sun AN; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):666-70. PubMed ID: 27587247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal.
    Li A; Wu Q; Davis C; Kirtane KS; Pham PD; Sorror ML; Lee SJ; Gopal AK; Dong JF; Garcia DA; Weiss NS; R Hingorani S
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):570-576. PubMed ID: 30940363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning.
    Willems E; Baron F; Seidel L; Frère P; Fillet G; Beguin Y
    Bone Marrow Transplant; 2010 Apr; 45(4):689-93. PubMed ID: 19718063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Mii A; Shimizu A; Kaneko T; Fujita E; Fukui M; Fujino T; Utsumi K; Yamaguchi H; Tajika K; Tsuchiya S; Iino Y; Katayama Y; Fukuda Y
    Pathol Int; 2011 Sep; 61(9):518-27. PubMed ID: 21884301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.
    Fujiwara H; Maeda Y; Sando Y; Nakamura M; Tani K; Ishikawa T; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanimoto M
    Transfusion; 2016 Apr; 56(4):886-92. PubMed ID: 26711692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.